Type 1 Diabetes and Coronary Artery Disease
Open Access
- 1 November 2006
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (11) , 2528-2538
- https://doi.org/10.2337/dc06-1161
Abstract
Although the increased risk of premature heart disease in type 1 diabetes has been recognized for some time, the underlying pathogenesis is still poorly understood. The most likely factor, a priori, to account for this increased risk is hyperglycemia. However, despite recent evidence from the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study that prior intensive glycemic control reduces cardiovascular disease (CVD), the epidemiologic association between glycemia and coronary heart disease (CHD) is surprisingly weak. This paradox is a focus of the current review, which also evaluates other major determinants of coronary artery disease (CAD) in type 1 diabetes, including the roles of insulin resistance, cytokines, inflammatory biomarkers, and, briefly, genetic factors. Finally, the clinical implications of this information are discussed. A high occurrence of, and mortality from, CHD in type 1 diabetes has been documented since the late 1970s (1,2). A 1984 registry reported a 10-fold or greater CHD mortality compared with that expected from U.S. national data (3). This very high relative risk, partly reflecting the extremely low CHD death rate in the general young-adult population, was subsequently confirmed by Joslin investigators (4), who reported that those with type 1 diabetes by 55 years of age experienced a sixfold greater cumulative CHD mortality compared with the rate expected using Framingham Study data. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) also reported a standardized mortality ratio (SMR) from ischemic heart disease of 9.1 (for men) and 13.5 (for women) for those with a diabetes diagnosis before 30 years of age (5). Two recent prospective epidemiologic studies, the Pittsburgh Epidemiology of Diabetes Complications (EDC) study (6) and Eurodiab (7), a multicenter, clinic-based study in Europe, confirmed these earlier reports and reported an incidence of total coronary events (including electrocardiogram [ECG] changes) …Keywords
This publication has 156 references indexed in Scilit:
- The −514 C/T polymorphism in the hepatic lipase gene promoter is associated with insulin sensitivity in a healthy young populationJournal of Molecular Endocrinology, 2005
- Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based studyJournal of Medical Genetics, 2004
- Genetic polymorphisms of the renin–angiotensin system and complications of insulin‐dependent diabetes mellitusNephrology Dialysis Transplantation, 2000
- Increased incidence of moderate stenosis among patients with diabetes: Substrate for myocardial infarction?American Heart Journal, 1997
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.Journal of Clinical Investigation, 1997
- Composition of atherosclerotic plaques in the epicardial coronary arteries in juvenile (Type I) diabetes mellitusThe American Journal of Cardiology, 1992
- Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitusAmerican Heart Journal, 1991
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusThe American Journal of Cardiology, 1987
- Prognosis of diabetics with diabetes onset before the age of thirtyoneDiabetologia, 1978